Charles Schwab’s Tenax Therapeutics TENX Stock Holding History

Charles Schwab’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$890K	Buy	+61,174	New	+$781K	﹤0.01%	3036

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Charles Schwab's TENX Position: Q2 2026 in Review

Charles Schwab opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 61,174 shares worth $890K. The stake represents ﹤0.01% of the portfolio and ranks #3036 among its holdings.

111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Charles Schwab held 61,174 shares of Tenax Therapeutics worth $890K as of Q2 2026.
Tenax Therapeutics was a new Charles Schwab position in Q2 2026.
Tenax Therapeutics made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3036 holding.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.